Combination of | |
---|---|
Panipenem | Carbapenem antibiotic |
Betamipron | Inhibitor of renal panipenem uptake |
Clinical data | |
Trade names | Carbenin |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intravenous |
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
KEGG |
Panipenem/betamipron is a carbapenem antibiotic[1] marketed by Daiichi Sankyo Co. of Japan. It was launched in 1993,[2] under the brand name Carbenin.[3]
It is a combination in which panipenem is the carbapenem antibiotic and betamipron inhibits renal uptake of panipenem[4] and so reduces its nephrotoxicity[5] (much like the imipenem/cilastatin combination).